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ABSTRACT 
Internal parasitism inevitability prompts economic loss in beef cattle production by decreasing 
growth performance and reproductive traits. Today, the most widely used class of anthelmintic 
used to treat parasitism, is the macrocyclic lactone. Many studies have conflicting results on the 
efficacy of macrocyclic lactones (ML) efficacy against internal parasitism. The objective of this 
study was to evaluate the effectiveness of moxidectin and eprinomectin, two of the MLs, on cow 
performance. Multiparous fall calving, crossbred beef cows (n = 106) were allocated randomly to 
1 of 3 anthelmintic treatments: 1) Negative control (CON), in which cows did not receive an 
anthelmintic, 2) Injectable moxidectin (MOX) and 3) Injectable extended release eprinomectin 
(ERE). Anthelminthic administration occurred on d 0, just prior to calving. Body weights (BW), 
body condition scores (BCS), and fecal egg counts (FEC) were obtained throughout the duration 
of the calving season until weaning, occurring on days: 0, 80, 162, and 217, with weaning 
occurring on d217.  FEC were obtained, and body weights were recorded for calves on d162 and 
d 217.Performance data were analyzed using the MIXED procedures of SAS, and pregnancy 
data were analyzed using the GENMOD procedures of SAS. Significance was fixed at P < 0.05 
and tendencies were established from 0.05 ≤ P ≤ 0.10. There was no effect of anthelmintic 
treatment on cow BW (P ≥ 0.57) or cow BCS (P ≥ 0.22) during the 217 d study; however, CON 
cows tended to have lower BCS (P = 0.08) throughout the duration of the study. Cows treated 
with ERE had lower FEC compared to MOX and CON groups (P ≤ 0.001), as well as a tendency 
for improved pregnancy (2  = 0.0735), and calving (2  = 0.007) rates compared to the MOX 
treated group. Calf average daily gain (P = 0.23) and weaning weight (P = 0.35) was similar 
regarding CON, MOX, and ERE dam treatments. Calf fecal egg counts tended to differ in 
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There is an unquestionable certainty of negative effects and financial loss associated with 
internal parasitism in beef cattle productivity. Losses that are inherently common to parasitism 
include decreases in body weight gains, milk production, reproductive rates and body condition 
scores. This, in combination with decreased feed intake, inhibition of nutrient utilization, 
metabolism disruption and declining immune status of the animal further compounds the losses 
endured both physically by the animal, and financially by the producer (Kunkle et al., 2013). 
Actions advised for negating these parasite- associated production losses include strategic 
pasture rotation management practices, keeping animals in a good nutritional status and the 
correct use of anthelminthic products, taking into account treatment timing, product selection, 
and administration. The objective of this study was to evaluate the efficacy of two commercially 
available anthelmintic products on cow and calf performance measurements in a fall calving beef 







Trichostrongylids, more commonly known as Trichostrongyles, belong to the 
superfamily Trichostrongylicae. The nematodes within this superfamily are known for their 
small mouths, slender bodies, and similar life cycles. These parasites can measure anywhere 
between 450-20,000 microns, which are species and stage dependent. Trichostrongyles are 
considered to be the most important nematodes in ruminants due to the high level of 
pathogenicity they can achieve within the animal. Mixed infections are the norm, so it is hard to 
distinguish which species cause particular symptoms, due to the shared spectrum of affects and 
pathogenicity. Some of the most common genera in this family that can infect cattle include:  
Trichostrongylus spp., Haemonchus sp. , Cooperia spp. , Ostertagia sp. and Nematodirus sp. 
(Levine 1968; Cydectin Pour On Technical Manual,1998). 
Trichostrongylus Life cycle  
Levine (1968) describes the life cycle of the Trichostrongylus type worms as being 
mostly the same with some variability between species. Generally, the adult worms will produce 
eggs that will be excreted within the feces of the animal into the environment. Depending on 
whether environmental conditions are conducive enough to provide suitable oxygen, water and 
appropriate temperature, the egg will take about a day or more before hatching a first stage 
rhabditiform larva (L1).  
These (L1) larvae survive by feeding on bacteria and other microorganisms that are in the 
surrounding fecal pat for a day or more and if conditions are still favorable they will molt into a 




around them for a few days until they molt into a third stage ensheathed infective stage larvae 
(L3). 
The total time from egg excretion within the feces into an infective L3 larvae can take as 
little as 6 days or as long as several weeks depending on temperatures and other microclimatic 
affects that can interfere with development. Once the larvae have reached the L3 stage they 
migrate out of the fecal pat where many crawl up vegetation or stay on the soil’s uppermost 
surface. During this time, the ensheathed larvae can survive from days to months, utilizing food 
material stored in their cells. When a suitable hosts ingests the L3, the nematode will undergo 
exsheathment of their cuticle and will begin the parasitic phase of the life cycle in the 
gastrointestinal tract of the animal. At this point, depending on the species, larvae can begin 
exhibiting feeding behavior whether that is consuming tissue or taking blood meals from the host 
animal. The larvae molt twice more, once into a fourth stage larvae (L4) , and then finally into 
adolescent L5’s , just prior to development into mature adult worms.  
The adult worms will continue to remain in their designated region within the 
gastrointestinal tract and reproduce.  The species of the nematode determines the expected time it 
may take to develop into a reproductively capable adult, which is termed pre-patency as well as 
determine the time frame in which the adult is actively reproducing within the host, otherwise 
known as patency. There are many factors which can influence this timeline as well, such as: 
season of the year, intraburden inhibition, age,sex, species, and previous infection history of the 
host animal.   
Furthermore, nematode egg survival within the environment can also influence the 
epidemiological cycle of a host animal becoming infected. Evidence of microclimatic effects on 




done in central west Argentina where fecal pats were placed in three different environments (sun, 
shade, and the laboratory) during three seasons of the year (summer, autumn, and fall). In this 
study, mean temperature and fecal water content (FWC) inside the pats were measured in order 
to determine effect on larval rates of development. 
The genera of nematode eggs used in this study included: Haemonchus, Cooperia, 
Ostertagia and Oseophagostomum. The rate of development of larvae was demonstrated by the 
number of L3, which were extracted via the Baermann procedure, per 100 eggs deposited within 
the fecal pats.  
It was observed that 78% of the variability of development of all genera nematode eggs 
into L3 larvae was explained by the following three variables: the mean temperature during the 
total duration of development, the mean temperature during the first one-third of the duration of 
total development and the minimal fecal water content.  
In regards to Haemonchus species in particular, the mean temperature value and the 
minimal value of FWC explained 54% of the variability for the development of L3 larvae. 
Whereas, the mean maximal temperature and the minimal FWC values were the two main 
factors that determined the development of Cooperia species. Overall, developmental rates were 
higher in pats that were located in the shade during the summer and highest in locations that 
experienced more sunshine during the autumn season ; whereas, the laboratory conditions 
yielded more variability with its results on rate of development (Rossangio and Gruner,1994). 
Important Internal Parasites of Cattle  
Cooperia spp. 
There are many different species of Cooperia that affect cattle, some of the most common 




gastrointestinal inflammation/damange by penetrating the small intestine mucosa and causing 
acute inflammation, which increases the mucus production within the intestinal tract. Some 
animals may present with thickened mucosa accompanied by purple colored lesions upon 
necropsy (Cydectin Pour On Technical Manual, 1998).  
Cooperia is most pathogenic when it is present in young calves and causes clinical 
symptoms of: enteritis, diarrhea, emaciation and death. In a study by Alicata and Lynd (1961), 
five calves were experimentally administered 250,000 C. punctata larvae and five calves were 
left to serve as the control group in order to measure growth rates and observe other signs of 
infection. The resulting clinical signs of infection consisted of soft feces, intermittent or 
continued diarrhea, progressive emaciation, reduced feed consumption, weight loss and 
listlessness in infected calves.  
Nematodirus helvetianus  
Nematodirus, known as the thread necked worm, resides exclusively in the small intestine 
of young cattle. Its eggs are easily distinguishable from the other trichostrongyle type eggs, due 
to it’s larger size and football shape. In heavy infections L4 larvae and adults cause the atrophy 
of villi and inflammation within the intestine (Cydectin Pour On Technical Manual, 1998). This 
results in disruption of digestive function and negatively affects nutrient absorption. The 
common signs associated with an infection of N. helvetianus are anorexia, diarrhea, and 





The HOT Complex 
Of the various nematode species that are found within the gastrointestinal tract of cattle, 
some of the most important are those that are known to comprise the ‘HOT’ complex. This 
complex includes the genera: Haemonchus sp., Ostertagia sp., and Trichostrongylus spp. 
(Emery, 1996). 
Haemonchus placei   
Haemonchus, commonly called the barberpole worm, draws a large amount of blood 
from the animal in the L4 and adult stages during its life cycle within the host animal (Cydectin 
Pour On Technical Manual, 1998). They are particularly known for injecting an anticoagulant 
into the place of attachment at the mucosal surface so that the host loses more blood, usually 
more than the worm can physically ingest. This explains the hemorrhagic nature of the intestines 
commonly found upon necropsy in the host animal. Animals infected with large numbers usually 
show signs of: anemia, edema, emaciation, submandibular swelling, weakness, pale mucus 
membranes and weight loss (Levine,1968). 
Ostertagia ostertagi 
Ostertagia, commonly known in cattle as the brown stomach worm, is also a blood 
sucking nematode in all larval and adult stages of its life cycle and is considered to be the most 
important cattle parasite in the United States (Cydectin Pour On Technical Manual, 1998). There 
are three types of ostertagiasis that present in cattle, where Type 1 ostertagiasis consists of the 
classic disease in calves that display diarrhea and weight loss when exposed to the parasites for 
the first time on pasture. The ingested larvae in these calves develop to mature adults in about 21 




Pre-type 2 ostertagiasis occurs when the infective larvae are picked up during the grazing 
season and arrest within the abomasal wall for extended periods as opposed to continued 
development (type 1). This arrestment is due to Ostertagia’s ability to sense that the environment 
outside the host is not suitable for larval development and/or survival. In northern climates, this 
occurs in the autumn and winter, and in the southern regions, it occurs in late spring and most of 
the summer (Cydectin Pour on Technical Manual, 1998). 
Type 2 ostertagiasis is a condition that transpires when previously arrested larvae are 
signaled to continue their course of maturation. This occurs in the late winter and early spring in 
the north, and in the south it occurs during fall. During this time, a large amount of the 
previously arrested pre-type 2 larvae become active in the abomasal mucosa, causing immense 
tissue damage, inflammation, fluid loss, and hyperemia. Acute and abrupt symptoms similar to 
Type 1 ostertagiasis, such as diarrhea, weight loss, and subcutaneous swelling will also arise. 
The morbidity and mortality levels associated with this disease are largely dependent on the level 
of infection and magnitude of emergence of the previously arrested larvae in the type 2 disease 
state. (Cydectin Pour On Technical Manual, 1998; Martin et al., 1957; Anderson et al., 1965; 
Myers and Taylor, 1989). 
Trichostrongylus axei  
According to Levine (1968), T. axei can be highly pathogenic in large numbers. Once 
ingested, T. axei larvae migrate to the abomasal mucosa where they cause lesions, which 
contribute to mucosa inflammation, hyperemia and sloughing of the epithelial tissue that lines 
the intestinal tract. Doran (1955) found infections of T. axei to cause weight loss, loss of appetite, 





Other, Less Common Parasites of Concern in Cattle  
Bunostomum phlebotomum 
Bunostomum, also known as the cattle hookworm, enter the host by skin penetration 
before migrating to the host’s small intestine. As described by Levine (1968), the first sign of 
Bunostomum phlebotomum infection is hives, skin irritations, and animals itching their lower 
legs due to larval entrance through skin penetration, when the infection is percutaneous. Animals 
will later become anemic and experience diarrhea due to the blood sucking nature of the adult 
worms within the small intestine. The intestinal mucosa will become fluid filled and may or may 
not be accompanied with blood. Clinical signs are mostly observed in calves, as adult animals 
commonly acquire immunity due to previous infections (Cydectin Pour On Technical Manual, 
1998). 
Oesophagostomum radiatum   
Commonly referred to as the nodular worm, O. radiatum is unlike Bunostomum in that 
the majority of the pathogenicity and intestinal destruction that the animal endures is due to the 
pre-patent larvae and not the actively reproductive adult worms (Cydectin Pour On Technical 
Manual, 1998). This nematode can infect the animal upon ingestion, or via skin penetration. 
According to Andrews and Maldonado (1942) and Mayhew (1948), the 4th stage larvae 
become encapsulated in nodules in the mucosa within the small and large intestine. These small 
raised areas grow over time to form abscesses, which may be fluid filled and may contain blood. 
These nodules eventually cause the intestinal tract to become greatly inflamed, and with repeated 
infections can be severe to the animal’s health. The animal may then experience upset to their 





Monezia benedini  
Monezia is a helminth of the family Cestoda or more commonly known as tapeworms. 
Pathogenicity is fairly low and usually does not cause a major concern in the health of cattle 
unless found in large numbers. Tapeworm infections in cattle occur by cattle ingestion of an 
infected free-living mite on pasture. The mite serves as an intermediate host where the larval 
stage of the tapeworm occurs within the mite. Once the cattle ingest the mite, the larva are 
released from the digested mite and attach to the mucosa of the small intestine. The tapeworm 
will continue a process called strobilation until it reaches full maturity. At this time, the adult 
tapeworm will shed eggs, or gravid proglottids from the posterior end of the tapeworm. These 
shed eggs are ingested by a free-living mite which commences the life cycle of a new tapeworm.  
Tapeworms do not cause severe intestinal trauma in cattle. There have been some 
observed negative effects of tapeworm burdens in calves, including intestinal irritation, and 
digestion issues with resulting diarrhea and unthriftiness (Porter, 1942). 
Coccidia 
The term coccidia is the common name used to describe the single cell protozoan parasite 
known as Eimeria spp. that is often observed in ruminant animals. These parasites are normally 
not a concern with grazing cattle, as they do not usually cause clinical signs of disease even in 
high numbers, but in some instances, as with young or stressed animals, they cause mucosal 
tissue destruction, erosion, and petechial hemorrhage (Jolley and Bardsley, 2006).  According to 
Matjila and Penzhorn, (2002) the estimated annual loss that cattle ranchers endure due to 
coccidiosis reaches upwards of $400 million due to reduced feed efficiency, stunted weight gain 




These coccidian parasites develop in the intestinal cells of the animals, and complete an 
elaborate life cycle eventually resulting in the voiding of oocysts into the feces. If environmental 
conditions are favorable, these oocysts can survive on vegetation, water sources, and other places 
where animals are maintained, for extended periods of time. As stated previously, though regular 
infections are common they usually do not cause clinical signs due to a buildup of challenge 
induced immunity. The trouble with the coccidian species occurs when the immune adult 
animals shed fairly large numbers of oocysts on the shared vegetation with naïve calves, which 
have yet to endure an initial sensitizing infection. Calves that are immunologically naïve to 
coccidian infections can become susceptible to a serious state of disease when placed in highly 
contaminated areas and faced with stressful events such as: weaning, shipping, changes in feed, 
crowding, and concurrent infections with other parasites. Calves diagnosed with coccidiosis 
usually present with bloody diarrhea, dysentery, dehydration, weakness and emaciation (Jolley 
and Bardsley, 2006). 
Brief history of anthelmintics and their modes of action 
In the years that preceded 1960, the anthelmintic products available were not 
exceptionally effective at reducing parasite burdens and in some cases were actually harmful to 
the health of the animal, with some containing arsenical and nicotine. Some compounds 
introduced in the early 1960’s such as morantel tartrate were recognized for their relatively high 
level of efficacy against parasitic burdens in livestock, but they are either no longer produced or 
used. These products were referred to as the early modern anthelmintics and were soon replaced 
by the second generation benzimidazoles in the late 1970s and throughout the 1980s. These 
products were used extensively due to their welcomed high level of efficacy against 




fluke control. In 1984, the latest class of deworming products were introduced, and are referred 
to as the endectocides meaning that they worked against both internal and external parasites, but 
did not have activity against liver flukes or tapeworms. The first product released from this new 
drug class of macrocyclic lactones is called ivermectin (Williams and Loyacano, 2001).  
The three major classes of anthelmintics that are approved for use in cattle today as 
outlined by Edmonds et al. (2010) includes the imidazothiazoles, benzimidazoles and 
macrocyclic lactones. Imidazothiazoles used in cattle is limited to the drug known as levamisole. 
Benzimidazoles include drugs such as albendazole, fenbendazole, and oxfendazole. The 
macrocyclic lactones are subdivided into two groups referred to as the avermectins, which 
includes ivermectin, doramectin, eprinomectin , and the milbemycins represented only by 
moxidectin in cattle.  
Imidazothiazoles mode of action 
According to Vercruysse and Claerebout (2019), this class of drugs work by attaching to 
nicotinic acetylcholine receptors within the nematode’s nerve cells, resulting in spastic paralysis.  
The subsequent paralysis of the nematode allows it to be expelled by the peristalsis action of the 
host animal. 
Benzimidazoles mode of action 
Benzimidazoles work against the nematodes, cestodes, and trematodes by selectively 
binding to the heminth’s beta- tubulin molecules, thereby inhibiting microtubule production, 
which in turn causes the parasite to slowly die due to loss of intracellular transport mechansisms. 
Martin (1997). Inhibition of microtubule formation induces the disruption of cellular transport 
and energy metabolism, which in turn depletes energy reserves as well as disrupts the excretion 




parasite, which in turn inhibits its ability to function properly and decreases worm survivability 
(Vercruysse and Claerebout, 2019).  
Macrocyclic lactones mode of action 
The avermectin, and milbemycin subgroups within the macrocyclic lactone class have 
minor differences in their molecular properties relative to parasiticidal activieies, but generally 
both work against the nematode by increasing the opening of the glutamate gated chloride 
(GluCl) channels, which allows for an influx of chloride ions into nervous and muscular tissue. 
The influx of these chloride ions causes paralytic effects on different neuromuscular systems 
such as the pharynx, reproductive tract and the body wall of the parasite. The paralysis of the 
body wall musculature allows the parasite to be immobile, and susceptible to rapid expulsion by 
the host animal via peristalsis. Paralysis of the pharynx inhibits the ability of the parasite to feed 
which results in worm death by starvation (Vercuysse and Claerebout, 2019).  
Anthelmintic resistance  
Over the past few decades there has been an observed decrease in the efficacy of 
anthelmintics due to an increased resistance by the nematodes to the anthelmintic drugs we rely 
on in order to protect our cattle from parasitic infections. Resistance is said to be present when 
the frequency of the individuals within a parasite population that would normally be affected by 
a dose or the concentration of a compound are no longer affected by that dose or concentration 
and require a greater amount for a certain level of efficacy (Wolstenhome et al., 2004). 
Resistance is generally confirmed when there is less than 90% reduction in geometric mean 
worm count population after treatment administration. (Taylor et al., 2002) 
Additionally, it has been reported that multidrug resistance for many species of parasites 




observed for one anthelmintic in a class, that there is also some level of resistance to other drugs 
in the same class as well (Wolstenhome et al., 2004). Partial contribution to the increased 
resistance can be attributed to the fact that many producers strictly rely on drug administration 
for worm control, while neglecting husbandry and managerial options such as good pasture 
management practices in order to reduce contamination, maintaining refguia in a herd. (Gasbarre 
et. al, 2009; Kaplan and Vidyashankar, 2012; Demeler et al., 2010). Resistance is not confined to 
the United States, but has become a worldwide concern as resistance has been observed in the 
UK, New Zealand, Argentina, and Brazil (Coles, 2002 ; Soutello et al., 2007;Suarez and Cristel , 
2007 ; Kaplan and Vidyashankar , 2012 ; Gasbarre et al., 2009 ; Anziani et al., 2004 ; Chaudhry 
et al., 2014).  
Cooperia species are perhaps the most often cited as being resistant to the avermectin 
drug class. Due to their observed abundance and ability to achieve pathogenic populations in 
young cattle, Cooperia infections in calves cause high levels of morbidity and subsequent 
mortality that is not curbed with routine anthelminthic intervention (Edmonds et al., 2010; Fiel et 
al., 2001; Anziani et al., 2001; Mejia et al., 2003). 
In one study, Edmonds et al. (2010) used 50 yearling heifers with a known history of 
harboring anthelmintic resistance nematodes. They were treated with either: injectable 
ivermectin, injectable moxidectin, oral fenbendazole, oral oxfendazole, or injectable saline 
control. Upon necropsy, the results of the trial showed that fenbendazole and oxfendazaole 
efficacy against Cooperia spp. was greater than 95% while moxidectin resulted in 88% parasite 
reduction and ivermectin treated heifers resulted in no reduction in adult Cooperia spp. These 




adult Cooperia spp., specifically Cooperia oncophora; further demonstrating the resistance and 
dose limiting nature of this species against all drugs of the macrocyclic lactone class. 
Anthelmintics of Interest 
Moxidectin 
As mentioned previously, moxidectin falls into the subclass milbemycin, which is 
included in the family of anthelmintics known as the macrocyclic lactones. According to 
Vercruysse and Claerebout, (2019) these products are well absorbed when administered orally 
and by way of injection whereas when used in formulation as a pour on, the substance has a 
more variable absorption within the animal. This particular anthelmintic concentrates within the 
adipose tissue of the animal upon administration, which accounts for its ability to sustain 
concentrations that allow it to be actively effective against parasites over an extended period of 
time.  
Performance of cattle treated with Moxidectin 
There have been various studies constructed in order to determine the efficacy of 
moxidectin (MOX) as an anthelmintic product when used in cattle (Whang et al.1994 ; 
Reinmeyer and Cleale, 2002 ; Maritorena-Diez et al., 2005 ; Ives et al.,2007;Walker et al., 2013; 
Yazwinski et al.,2013 ; Powell et al.,2008; Cleale et al., 2004). Moxidectin treated cattle have 
been observed to have an increase body weight (Walker et al., 2013; Whang et al., 1994) and 
increased average daily gain (Cleale et al., 2004; Powell et al., 2008) as compared to controls.  A 
study conducted by Yazwinski et al. in 2006, observed significant improvements for average 
daily gains in cattle receiving MOX injections at multiple dose rates as compared to those 
control animals in a combination of three studies which took place in 3 different geographical 




interval or the dose rate of moxidectin, a 33% increase in average daily gain in cattle was 
observed in treated cattle compared to those that were in the control groups.  
Moxidectin effect on fecal egg count reduction 
Along with performance data there have been studies that have observed the effects on 
fecal egg count reductions in Moxidectin treated cattle when compared to other macrocyclic 
lactones (Soutello et al., 2010; Ives et al., 2007; Yazwinski et al., 2013) as well as compared to 
control animals (Maritorena-Diez et al., 2005; Cleale et al., 2004; Whang et al., 1994; Powell et 
al., 2008).  In one study reported by Yazwinksi et al. (2013), 24 study calves that were believed 
to have had no prior anthelmintic treatment were blocked into 4 treatment groups: control, 
topical ivermectin, topical moxidectin and injectable moxidectin. Two weeks after treatment 
administration a fecal egg count reduction test showed a 93% fecal nematode reduction with 
injectable moxidectin and upon necropsy (15-18 days post treatment) the topical formulation of 
moxidectin resulted in (>90%) efficacy against all common nematodes for cattle.  
Eprinomectin extended release formulation 
Eprinomectin is a semi-synthetic compound of the avermectin sub group that was 
originally formulated for topical administration for the use of nematode, insect, and mite control 
in cattle. Due to its capacity to be reformulated into a unique micelle matrix it was formulated as 
such and evaluated as well as market as an anthelmintic that would extend the therapeutic 
effectiveness in treated animals for prolonged period of time of about 120 days. (Soll et. al, 
2013).  
One of the driving forces behind the popularity of this extended release product was the 
convenience factor for cattle producers. The ability for a single product administration for season 




release formulation consists of a 5% sterile solution of eprinomectin incorporated in a poly (D, 
L-lactide-co-glycolic) acid (PGLA) polymer matrix. Following subcutaneous injection at a dose 
of 1.0 mg/kg BW, eprinomectin is released from the PGLA matrix at injection site. The 
eprinomectin plasma concentrations remain therapeutic for approximately 100 days post 
treatment, with an augmenting additional spike at day 70 post treatment. After this second spike, 
there is a gradual decline of plasma eprinomectin concentration until approximately day 150 
post-original administration. This unique technology of an extended release confers extended 
nematode control anywhere from 100-150 days after a single administration (Forbes, 2013).  
Performance of cattle treated with Eprinomectin 
Eprinomectin has been observed to improve performance parameters of cattle treated 
with extended release formulation as opposed to those that were treated with injectable 
ivermectin (Andresen et al., 2018) as well as when compared to control animals (Rehbein et al., 
2013).  
A study by Andresen et al. (2018), used two experiments to determine performance and 
reproductive success of a fall calving beef herd of cows that were treated with either extended 
release eprinomectin or conventional injectable ivermectin. In the first experiment, 119 fall 
calving cows were assigned to either a treatment of injectable ivermectin (n=53, CONV) or 
injectable extended release eprinomectin (n=66, EPR). The performance results of the study 
showed that cows treated with EPR observed not only a greater average daily gain, but also a 
greater change in body weight (P ≤ 0.01) compared to CONV treated cows. The reproductive 
performances observed in the study presented a tendency for higher pregnancy rates in cattle that 
were administered EPR as opposed to those in the CONV treatment group (P = 0.15). In addition 




weaning weights, even at a younger age compared to those calves from the CONV treated cows 
(P ≤ 0.01).  
 In the second experiment in this study, 74 yearling fall replacement heifers were 
similarly placed in treatment groups represented by the first experiment (n=33; CONV) or (n=44; 
EPR). The performance evaluation showed that EPR treated heifers attained heavier body 
weights (P ≤ 0.10), a greater weight gain (P ≤ 0.01), and greater daily gain (P ≤ 0.01) compared 
to those heifers administered the CONV treatment. The reproductive performance data in regards 
to the heifer treatment groups also revealed that EPR treated heifers overall pregnancy rates were 
greater (95%) compared to CONV treated heifers (73%).   
Eprinomectin effect on fecal egg count reduction 
There have been many studies over the years that have demonstrated a high therapeutic 
efficiency and acceptability of extended release eprinomectin (EPR) when used in cattle to treat 
multiple species of gastrointestinal and pulmonary nematodes, including those that are inhibited 
within the host (Hunter et al., 2013; Rehbein et al., 2013; Soll et al., 2013; Rehbein et al., 2013).  
In addition to a record of high therapeutic efficiency against nematode infections, EPR has also 
been demonstrated to confer anthelmintic activity for extended periods of time ranging anywhere 
from 100-150 days post treatment depending on the species of nematode (Soll et al., 2013; 
Rehbein et al., 2013).  
A total of 10 studies were used collectively in order to observe the duration of efficacy in 
different breeds of cattle in different geographical areas wherein the cattle were challenged with 
nematode infections from 100- 150 days following treatment with EPR. Of the 10 studies, 5 took 
place in the U.S., 1 took place in the U.K. and 4 took place in Germany. Study 1 and 2 were 




infections in cattle for 100 to 120 days after treatment, studies 3-8 were created to evaluate 
efficacy after 120 days post treatment, and studies 9 and 10 were created to evaluate efficacy 
after 150 days post treatment.  All studies were conducted by randomized block design based on 
pretreatment body weights.  
Cattle used to test the efficacy of EPRI against a single challenge of infective stage 
gastrointestinal nematodes at 100 days post treatment exhibited an overall nematode reduction of 
>99%. Treated cattle had fewer (P < 0.01) nematodes of the species: C. oncophora, C. 
surnabada, C. punctata and T. axei as compared to those animals that were treated with control 
saline injections.  
Cattle used to test the efficacy of EPRI against a single challenge of infective stage 
gastrointestinal nematodes and/or lungworms after 120 days post treatment were shown to 
exhibit an overall nematode reduction of ≥92%. These treated cattle also had significantly fewer 
(P <0.05) of the following species: H. contortus, O. lyrata, O. ostertagi, O. leptospicularis, O. 
circumcinta, O. trifurcata, T. axei, C. punctata, B. phlebotomum and O. radiatum, as compared 
to the control cattle injected with saline.  
Lastly, cattle used to test the efficacy of (EPRI) against a single challenge of infective 
stage nematodes at 150 days post treatment were shown to have an overall nematode reduction 
of ≥92%. These EPRI treated cattle harbored significantly fewer nematodes (P <0.01) of the 
species: H. contortus, B. phlebotomum, O. radiatum, when compared to cattle that were treated 
with the saline injection, serving as a control. Therefore, these studies confirmed the high 
efficacy of the extended release eprinomectin formulation against nematode challenge at 100, 






Fenbendazole is a broad spectrum anthelmintic that falls in the benzimidazole drug class 
and is most commonly used to treat nematode infections in livestock. It is available in various 
formulations such as a bolus, suspension, or paste. It is most commonly administered orally due 
to its lack of water solubility, and the ability of the compound to transfer to the parasite by 
transcuticular diffusion after absorption through the gastrointestinal tract.  (Vercruysse and 
Claerebout, 2019; Enejoh and Suleiman, 2017). 
Performance of cattle treated with Fenbendazole 
In a study conducted by Troxel et al., (1993)  fenbendazole (FEN) was administered to 
cows in an oral suspension at the rate of 5 mg/kg of body weight, 45 to 60 days prior to calving. 
Though the calves born from treated dams had a resulting 15.3 percent increase in ADG 
compared to calves born from untreated dams, the observed differences were not deemed 
significant.   
The results of a two year study conducted by Stromberg et al., (1997) further supports the 
idea that cows treated with FEN have increased reproductive performance when compared to 
control cows and that calves treated with FEN significantly outgained non-treated control calves. 
In the first year of this study, 60 cows and 12 bred heifers were stratified and randomly allocated 
to either treated or control groups. Similarly, in the second year of the study, 61 cows and 4 bred 
heifers were used in order to compare variances over the successive two years. Cows receiving 
anthelminthic treatments were administered an oral fenbendazole suspension at the dose rate of 5 
mg/kg of bodyweight just prior to turnout on spring pasture. Control cows did not receive an 
anthelmintic treatment. Cows and calves in the treatment groups were administered an oral 




to fresh pastures. Both groups grazed on similar but separate pastures for the duration of the 
study. The results of the study had shown an increase (P = 0.0357) in reproductive performance 
in the FEN treated cows over the course of the two-year study with an 11.8% and 12.4 % 
increased pregnancy rate as compared to the control groups in years 1 and 2 of the study. It was 
also observed that the FEN treated calves had an increased average daily gain of 0.13 kg 
compared to control calves as well as FEN treated calves weaning at 18.5 kg heavier compared 
to those control calves (P = 0.0001).  
Fenbendazole effect on fecal egg count reduction  
As evidenced by the previously mentioned study by Troxel et al., (1993) FEN was shown 
to indirectly decrease fecal egg counts at 90 days of age in calves that were born to cows treated 
with FEN prior to calving as compared to those calves born from cows that were left untreated.  
Furthermore, Stromberg et al., (1997) observed that FEN treated cows and calves not 
only experienced increased performance compared to control animals but also exhibited lower 
fecal egg counts throughout the study as well. In his work, control cows experienced higher fecal 
egg counts in the collections that occurred in July (P < 0.0001) and October (P = 0.0083) as 
compared to the FEN treated cows during the study. The study also reported that calves treated 
with FEN had lower fecal egg counts (P < 0.0001) during the October collection at weaning as 
compared to control calves.  
Economics on deworming beef cattle  
In a study using six regional cow- calf operation budgets, Lawrence and Ibarburu (2007) 
evaluated the estimated costs of eliminating pharmaceutical products on calf weaning rate and 
the subsequent production costs. Of the pharmaceutical technologies investigated in this study, 




value of 23.6%, which leads to improved weaning rates. It should be noted that weaning rate 
includes both pregnancy rate and survival rate of the calf. Also, there was an observed 34% 
expected impact on a break even selling price when removing anthelmintic products within a 
beef cow calf operation, that correlated to an added cost to the producer of $165.47 per head.  
These findings are crucial in understanding the negative impacts that can occur when 
withholding anthelmintic treatment, and further convey the importance for continuing research of 
anthelmintic efficacy in different beef production systems.  
Conclusion  
Gastrointestinal nematode infections in cattle have negative impacts on cattle health and 
productivity. Proper deworming protocols and fecal egg count reduction tests can be useful in 
mitigating these production losses and negative effects on cattle performance when dealing with 
parasitic infections.  
As stated by Troxel et al., (1993), deworming programs have to take into account the 
costs and returns of deworming. Costs may include: the anthelmintic product, equipment, labor, 
and the gathering cattle and the returns may include: dam reproduction rates, cutting added 
production costs of supplemental feeding products and increased weaning weights in calves.  
Producers can properly use commercially available anthelmintic products such as moxidectin, 
extended release eprinomectin and fenbendazole as an important tool in order to implement 
effective management strategies that are conducive to combating the negative effects of 
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Evaluation of anthelmintic therapies in a fall calving beef cowherd 
 
INTRODUCTION 
It has been reported that conservatively, the economic losses in the cattle industry due to 
gastro-intestinal nematode parasitism reaches upwards of $2 billion per year in terms of 
productivity losses and increased production expenses, not including the costs associated with 
increased labor due to increased animal handling (Stomberg and Gasbarre, 2006). Unfortunately, it 
is understood that the actual losses are much greater as this estimation can only factor in observed, 
quantifiable losses and does not account for other subclinical losses which are believed to be even 
greater than what is actually measurable (Myers, 1988). There are three different forms of internal 
parasitism that can affect our cattle which are defined as: infection, economic, and clinical forms. 
In this ideology, production losses that are due to the internal parasitic infections in cattle, which 
are not apparent to the producers, falls into the economic form. These are believed to greatly 
exceed those losses that are obvious by mortality or the state of disease, which would be 
considered the clinical form of parasitism. Out of the three forms of parasitism, the economic form 
is believed to be by far the most challenging to assess due to the fact that the animal physically 
looks healthy, but without comparing performance of treated animals to control animals, the true 
impact would still be greatly unknown (Craig, 1988). This underestimation of economic 
production losses coupled with increasing resistance to many anthelmintic products poses a major 
threat to the ability to maintain the health and productivity of cattle against parasitic infections. Of 
the many species of parasites that are a concern for cattle productivity, those that warrant the most 




Various species within the subfamily Trichostrongylidae have been observed to show 
resistance to anthelmintic products of all drug classes due to continuous administration, which 
perpetuates selection driven resistance at an accelerated rate. With this knowledge, there has 
been much investigation into the commercially available extended release formulation of 
eprinomectin, which has a label indicating up to 150 days of efficacy against nematode 
infections in cattle after only one injection. This extended activity appears very beneficial for 
both the animal and the producer where the animal receives extended protection from parasite 
infections due to a “broken” infection process, and the producer saves money in labor costs from 
decreased gathering of cattle for treatment. Another advantage of an extended activity 
anthelmintic product is the possibility to slow down the rate of resistant nematode generation 
turnover with longer periods occurring between treatments compared to other commercially 
available products. (Rehbein et al., 2013).  
Therefore, the purpose of this study was to evaluate performance and fecal nematode egg 
reduction for cows and calves when administered either extended release eprinomectin or 
moxidectin anthelmintic therapies just prior to calving; as well as to evaluate performance and 
fecal nematode egg reduction for calves administered fenbendazole 55 days prior to weaning.  
MATERIALS AND METHODS 
Location and Animals  
This study was conducted at the University of Arkansas Cow Calf unit in Savoy, 
Arkansas and consisted of 106 multiparous beef cows and their respective calves. All cows used 
in this study were of an Angus cross breed type. Authorized farm personnel monitored animals 




and procedures were approved by the University of Arkansas’ Institutional Animal Care and Use 
Committee (approval # 19014). 
Experimental Design 
Cow Management  
This study consisted of a randomized block design in which 106 resident fall calving 
multiparous beef cows were stratified by weight and parity, before being randomly allocated to 3 
different treatment groups: negative control (CON), injectable moxidectin (MOX), and injectable 
extended release eprinomectin (ERE). Sample size of cow treatment groups are as follows: CON 
(n =38), MOX (n = 30), and ERE (n =38). Cows in the CON group served as negative control 
and did not receive any treatment. Cows in the MOX and ERE treatments groups were 
administered their respective anthelmintics following label instructions on dose measurements 
and route of administration. Cows in the MOX treated group received subcutaneous injections of 
1% sterile moxidectin (Cydectin®, Bayer HealthCare LLC, Shawnee Mission, KS) at a dose of 
0.2 mg/kg of bodyweight in the cranial portion of the shoulder.  Cows in the ERE treated groups 
received subcutaneous injections of 5% sterile eprinomectin (LongRange®, Merial Limited, 
Duluth, GA) at a dose of 1.0mg/kg of bodyweight in the cranial portion of the shoulder as well. 
Treatment was administered one week prior to fall calving in September 2018. Cows were left to 
comingle while grazing on permanent pastures throughout the duration of the study, unless being 
brought in for days where sampling occurred and with the exception of subgroup pasturing  
during the breeding periods. Pastures were primarily comprised of a mixture between warm 
season Bermudagrass and cool season endophyte – infected tall Fescue.  Unequal cow numbers 
in the MOX treatment group compared to the ERE treatment and CON group resulted due to 




had been previously confirmed pregnant were veritably open, as well as some naturally occurring 
calf loss after birth. These animals who were open or who lost calves were removed from the 
previously allocated group and therefore were not included in the study. 
On d0, cows were brought in from the pastures and processed through a chute to identify 
the animal according to its ear tag to confirm treatment group placement. Cows were then treated 
with their respective anthelminthic, a fecal sample was obtained, bodyweights (BW) and body 
condition scores (BCS) were recorded. All cows were worked through the chute in this fashion 
on d 80, d 162, and d 217 of the study with weaning occurring on d 217. All fecal samples were 
stored at 4°C prior to being processed for FEC determination, expressed as eggs per gram (EPG). 
Calf Allocation  
Farm personnel processed 106 Angus crossbred fall born calves from the group of cows  
(n = 106) previously included in the study, as mentioned above. The fall calving season occurred 
from September 2018 to November 2018, in which time all calves were processed with a unique 
identification tag and had their birth weights recorded. Once processing was completed calves 
within each dam treatment group were stratified by weight and sex before being randomly 
allocated to a group of either negative control (CON) or oral fenbendazole drench (FEN) for later 
treatment. Of the 106 fall calves 46 of the calves were female and 60 of the calves were male. 
The 38 calves born from the CON group was comprised of 17 female calves and 21 male calves. 
The 30 calves born from the MOX group was comprised of 11 female calves and 19 male calves. 
The 38 calves born from the ERE group was comprised of 18 female calves and 20 male calves. 
Of the 106 processed calves 53 were allocated to the CON group and 53 were allocated to the 
FEN group. The CON group was comprised of 22 female calves and 31 male calves while the 





From d 0 to d 80 calves that were born were processed as mentioned above. On d 80 calves were 
brought in from the pastures and were individually processed through a chute to identify the 
animal according to its ear tag to confirm treatment group placement. Calves, ranging from 1 
month to 3 months of age, had their body weights recorded and received respiratory vaccinations 
(Pyramid 5 , Boehringer Ingelheim, Vetmedica, Inc.,St. Joseph, MO). On d 162 of the study, 
calves ranging from 4 to 6 months of age were worked individually through a chute to record 
body weights, obtain fecal samples and be administered anthelmintic treatment according to their 
assigned group. Calves that were allocated to controls were not treated and those that were 
allocated to FEN group were orally drenched with Fenbendazole (Safeguard®, Intervet Inc., 
Madison, NJ) at 5 mg/kg of body weight. At the time of weaning, d 217 of the study, calves were 
again processed through a chute to administer a second round of respiratory vaccinations, record 
body weights and obtain fecal samples for fecal egg count quantification. Calf ages ranged from 
6 to 8 months of age at the time of weaning. All fecal samples were stored at 4°C prior to being 
processed for FEC determination, expressed as eggs per gram (EPG). 
Fecal Egg Count  
Fecal samples were obtained directly from the rectum, by a poly shoulder length glove 
and then compressed to release excess air before sealing. These samples were taken directly to 
the University of Arkansas Parasitology lab to be analyzed for a FEC using 1 gram of feces and a 
magnesium sulfate (MgSO4) direct centrifugation- floatation technique.  This technique was 
performed for all cows and calves with cow fecal samples occurring on d 0, 80, 162, 217 and calf 
fecal samples occurring on d 162 and 217.One gram of fecal material from each animal was 




solution and hand homogenized with a metal spatula before straining through a 1 mm aperture 
sieve to remove large debris particles. The fecal solution was then placed in 15 mL test tubes and 
topped with a coverslip (22× 22 mm) before centrifugation for egg floatation. The coverslip was 
then removed and placed on a microscope slide to be viewed for egg quantification using a 
microscope at 40x magnification. Eggs were counted and recorded on a per gram basis (EPG).  
Statistical Analysis  
Quantitative measures for cow data included: BW, BCS, FEC, calving date and calving 
rate. Quantitative measures for calf data included: birth weight, BW, ADG, FEC, 205 day 
adjusted weaning weight, and gender frequency by treatment. These quantitative measures were 
analyzed using a mixed procedure of SAS. Fecal egg count values were transformed into log 
FEC values and transformed back to geometric means (GM) by taking the inverse of (log10 (x) -
1) for construction of the upcoming tables and figures. A 205 day adjusted weaning weight was 
calculated to adjust calf wean weights in order to allow for a fair age equivalent comparison 
among calves weaned between the ages of 160 – 250 days of age (Gould , 2015). This was 
calculated by using the following equation: (calf WW – calf birth weight)/ (wean date – calving 
date) * 205 + calf birth weight. Contrast statements were made for CON vs. Treated and MOX 
vs. ERE groups.  
Qualitative data such as pregnancy rate and calf gender frequency rate by treatment, was 
analyzed using GENMOD with a binomial distribution. Fixed effects for cow data was dam 
treatment, day, and day × treatment. The experimental unit was the cow. For calf data fixed 
effects were calf treatment, day, dam treatment, calf × dam treatment, and calf treatment × dam 
treatment × day. The experimental unit was the calf. All differences were considered with a P ≤ 





Cow Performance Results 
Body Weights (BW) 
In this study, weight gain was recorded to determine if treatment with ERE pre calving 
would result in greater weight gain than cows treated with MOX. Cow body weights followed a 
similar trend of day effect (P < 0.0001) from d 0 to d 217 from the time of calving to weaning 
with an average bodyweight of (544.1 ± 4.5 kg) and did not differ (P = 0.97) in regards to a dam 
treatment by day interaction. An orthogonal contrast statement revealed no difference of control 
versus treatment effect on cow BW (P = 0.38). There was also no observed effect of MOX 
treatment versus ERE treatment on cow BW (P > 0.92) ( Table 1; Figure 1). Pooled average 
body weight of cows from all treatments on d 0 was (573.8 ± 8.7 kg) and did not differ (P = 
0.97). From d 0 to d 80 all cows across treatments lost weight with a pooled average of (530.4 ± 
10.8 kg) and did not differ (P = 0.57). From d 80 to d 162 cows across all groups showed similar 
gain with a pooled average of (555.2 ± 8.2 kg) and did not differ (P = 0.89). From d 162 to d 
217, a similar loss in weight was observed across all treatments with a pooled average of (517.2 
± 7.8 kg) and did not differ (P = 0.90). ( Table 1; Figure 1).  
Body Condition Scores (BCS) 
Cow BCS also followed a similar trend of day effect (P < 0.0001) from d 0 to d 217 from 
the time of calving to weaning; with an average BCS of (5.4 ± 0.5), and with no observed 
difference on cow treatment by day interaction (P = 0.92).There was, however, an observed 
tendency ( P = 0.08) for dam treatment to have an effect on BCS. An orthogonal contrast 
statement of control versus treated revealed observed differences (P = 0.03) on cow BCS, where 




statement of MOX versus ERE cattle treatment had no observed differences (P = 0.48) on cow 
BCS. (Table 2;  Figure 2).On d 0 pooled average BCS across all treatments was (6.8 ± 0.1) and 
did not differ (P = 0.23). From d 0 to d 80 cows across all treatments experienced a similar loss 
of condition with a pooled average BCS of (5.4 ± 0.1) and did not differ (P = 0.82). From d 80 to 
d 162 cows across all treatments again experienced a similar loss of condition with a pooled 
average BCS of (5.0 ± .1) and did not differ (P = 0.22). Lastly, from d 162 to d 217 cows across 
all treatments experienced an even greater loss of condition with a pooled average BCS of (4.3 ± 
0.2) and did not differ (P = 0.48). (Table 2;  Figure 2).  
Cow fecal egg counts 
The observed geometric means of cow fecal egg counts were overall lower for ERE 
treated cattle (P = 0.003) from d 0 to d 217 of the study where the average FEC for ERE treated 
cattle was (1.3 ± 0.1 epg) ; (2.1 ± 0.1 epg) for MOX treated cattle and (2.3 ± 0.1 epg) for CON 
cattle. An orthogonal contrast statement of control versus treated revealed observed differences 
(P = 0.03) on cow FEC, where CON cattle were found to have higher FEC than those treated 
cattle. An orthogonal contrast statement of MOX versus ERE cattle treatment also observed 
differences (P = 0.007) on cow FEC, where ERE treated cattle had lower FEC compared to 
MOX treated cattle (Table 3). On d 0 pooled average of FEC across all treatments was (2.4 ± 0.2 
epg) and did not differ (P > .35). On d 80 control cows had a higher FEC observed than that of 
extended release eprinomectin and moxidectin treated cattle (P < 0.0001), but FEC of MOX 
treated cattle did not differ from ERE treated cattle (P = 0.16). FEC of treatments are as follows 
for ERE, MOX, and CON cows: 1.0 ± 0.1 epg; 1.9 ± 0.1 epg; and 5.0 ± 0.1 epg. On d 162 pooled 




pooled average FEC across all treatments was (0.9 ± 0.2 epg) and did not differ (P =0.45) (Table 
3).  
Cow reproductive performance 
Cow reproductive performance was measured by data acquired from both fall 2018 and 
subsequent 2019 fall calving seasons. Fall 2018 reproductive performance was measured by calf 
birth date and gender frequency distribution, while subsequent fall 2019 reproductive 
performance was measured by percent pregnant by natural breeding, percent pregnant by 
artificial insemination, overall pregnancy rate, subsequent fall calving rate and subsequent fall 
2019 calving date. There was no observed difference on fall 2018 calf birth date by dam 
treatment (P = 0.96). There were also no observed differences on control versus treated (P = 
0.96) or MOX versus ERE (P = 0.79) dam treatment effect on fall 2018 calf birth date (Table 4). 
Total herd calf crop which was comprised of calves from CON, MOX and ERE dam treatment 
groups yielded 106 calves, which was composed of 43% female calves and 57% male calves. Of 
the 38 calves born from the CON dam group, 45% were females and 55% were males. Of the 30 
calves born from the MOX dam group, 37 % were females and 63 % were males. Of the 38 
calves born from the ERE dam group, 47% were females and 53% were males. 
 Overall pregnancy rate for the fall 2019 calving season was 84% with pregnancy rates 
per treatment group ERE, MOX, and CON cows as follows: 92, 77, and 82 %. There was no 
observed anthelmintic effect on pregnancy rates across all treatments (P = 0.17) or effect on 
control vs. treated groups (P = 0.55); however, there was an observed tendency (P = 0.07) for 
ERE treated cows to have higher pregnancy rates than that of MOX treated cows (Table 5). 
Overall calving rate for the fall calving cow herd was 81% with calving rates per treatment group 




calving rate amongst the three treatments (P = 0.02) where ERE treated cattle had higher calving 
rates than those that were treated with MOX (P = 0.007). However, there was no observed 
difference in calving rates between control and treated groups (P = 0.87).(Table 5; Figure 3). 
There was no observed anthelmintic effect on percent pregnancies confirmed by natural breeding 
among treatments (P = 0.29), or by artificial insemination pregnancies (P = 0.17); however, there 
was an observed tendency (P = 0.06) for CON cows to have fewer AI confirmed pregnancies 
than treated cows. (Figure 4). There was no observed difference in anthelminthic effect on the 
following seasons’ calving date (P = 0.23), but there was an observed trend for treated cows to 
calve earlier than cows that were left as negative controls (P = 0.11) (Table 6).  
Calf performance results  
Birth weights 
 Calf birth weights were similar and did not differ among dam treatments: CON, MOX, or 
ERE (P = 0.14). Mean calf birth weights from CON, MOX, and ERE groups were: 32.0 ± 0.8 kg; 
32.5 ± 0.9 kg; 34.2 ± 0.8 kg, respectively (Figure 5).  
 Body Weights (BW) 
Calf weights were similar among FEN and CON treatments for d 162 (P = 0.53) and 
were not affected by a dam treatment of either CON, MOX, or ERE (P = 0.75).  A similar trend 
was observed for body weights of FEN and CON calf treatments on d 217 (P = 0.81) and were 
again not affected by a dam treatment (P = 0.91). On d 162 CON calves weighed and average of 
(179.1 ± 5.4 kg) while FEN treated calves weighed an average of (182.3 ± 5.3 kg). On d 217 
CON calves weighed an average of (221.2 ± 10.3 kg) while FEN treated calves weighed an 





Average Daily Gain (ADG) 
Calf ADG was observed to be similar between FEN and CON treatments from d 162 to d 
217 (P = 0.47) and was not affected by a dam treatment (P = 0.36). Control calves gained an 
average of (0.76 ± 0.1 kg/ day) while FEN treated calves gained an average of (0.73 ± 0.1 kg/ 
day) (Figure 7).  
Calf 205-day adjusted weaning weight 
 Observed calf 205-day adjusted weaning weights were similar and did not differ among 
FEN and CON calves in relation to dam treatment (P = 0.14), calf treatment (P = 0.92), and calf 
treatment × dam treatment interaction (P = 0.70). Mean calf 205 day adjusted weaning weight 
was (206.5 ± 3.5 kg) for the CON group and (207.0 ± 3.5 kg) for the FEN treated group. An 
orthogonal contrast statement for CON versus Treated dams, both MOX and ERE combined, did 
reveal a strong tendency (P = 0.0516) for dam treatment to have an effect on calf 205-day 
adjusted weaning weights (Figure 8). However, an orthogonal contrast statement of MOX versus 
ERE observed no differences (P = 0.93) on 205-day adjusted weaning weight of calves. Mean 
205-day adjusted weaning weights of calves according to CON,MOX, and ERE dam treatment 
groups were: 200.0 ± 4.1 kg; 209.9 ± 4.7 kg; 210.4 ± 4.1 kg, respectively (Figure 9).  
Calf fecal egg counts  
Observed calf fecal egg counts were similar (P = 0.19) among FEN and CON treatments 
on d 162, where CON calves had an average (9.8 ± 0.1 epg) while FEN treated calves had an 
average (12.0 ± 0.1 epg). On d 217, calves in FEN treated and control groups had a similar FEC 
(P = 0.79) where CON calves had an average (17.8 ± 0.4 epg) while FEN treated calves had an 




Though FEC were similar among FEN and CON calves in relation to calf treatment on d 
162; there was however, an observed tendency for calf FEC to differ in relation to dam treatment 
(P = 0.08) . On d 162 calves born from ERE treated dams had a lower FEC than calves born 
from CON dams ( P = 0.03) where calves from ERE dams had an average ( 9.3 ± 0.1 epg) and 
calves from control dams had an average ( 13.5 ± 0.1 epg). Calves born from MOX treated dams 
had an intermediate FEC of (10.1 ± 0.1 epg) that did not differ significantly from the FEC of the 
calves from the CON (P = 0.14) or  ERE ( P = 0.7) dam groups (Figure 11). 
DISCUSSION 
Observations of increasing anthelmintic resistance in parasites have driven the 
exploration for long-term solutions for nematode control in livestock species. In this study, there 
were two objectives: 1.) To evaluate the efficacy of two classes of commercially available 
macrocyclic lactones on beef cattle performance over a period of 217 days; 2.) To evaluate the 
egg count and performance effects of fenbendazole treated and non- treated control calves 55 
days before weaning.  
Cow Performance Discussion 
In this study, weight gain and body condition scores were evaluated to determine if 
treatment with ERE would result in a greater weight gain as compared to animals treated with 
MOX or those left as controls. The collection of body weight and condition score changes over a 
given time period are important aspects in determining cattle’s nutritional status (Ndlovu et al., 
2007) as well as overall health (Berry et al., 2006) and fertility (Buckley et al., 2003). The 
observational trend in similar loss of body weight and body condition score across all cow 
treatments in relation to a day effect from d 0 to d 80 is most likely attributed to the period of 




weight and body condition scores across cow treatments throughout the study is most likely 
attributed to the low worm burdens reflected by the low fecal egg counts observed in cows across 
all groups, indicating only a minor impact of worm infections on animal performance.  
Though we did not see sizeable effects of anthelmintic treatment on cow body weights or 
body condition scores throughout the duration of the study we did see an effect on cow fecal egg 
counts. Although fecal egg counts were considered extremely light throughout the duration of the 
study, ERE treated cows had overall lower fecal egg counts compared to MOX and CON cows 
throughout the study. On d 80 there was observed differences between CON and anthelminthic 
treated cows, where ERE and MOX treated cows had lower FEC than CON cows. Though the 
FEC for MOX treated cows was greater than that of ERE treated cows, there were no observed 
differences between these two groups. For CON cows these results are most likely attributed to 
the further natural pasture infection that would increase in an animal without the use of an 
anthelmintic treatment. For MOX treated cows these results would be attributed to the decrease 
in internal nematode populations upon initial treatment that would have provided an estimated 14 
to 42 days of internal nematode protection as stated in product label claims. This would have 
allowed for a reinfection period to occur, prior to secondary fecal collection on d 80. For ERE 
treated cows these results would be attributed to the decrease in internal parasitism populations 
upon initial treatment that would have provided anywhere from 100-150 days of internal 
nematode protection as stated in the product label claims. 
As stated in earlier results, dam treatment in fall 2018 prior to calving did not have an 
observed effect on fall 2018 calving dates. This is likely attributed to the late phase of gestation 




that calf gender frequency distribution among treatments was unaffected by dam treatment in the 
fall 2018 calf crop.  
Though there were no observed effects of fall 2018 cow treatment on cow reproductive 
performance for the fall 2018 calving season, there was observed differences for the subsequent, 
fall 2019, calving season. In this study, it was observed that those previously ERE treated cows 
with lower FEC had an observed tendency for higher pregnancy rates in the 2019 fall calving 
season compared to those previously MOX treated cows. In addition to this, there was also an 
observed effect on calving rate, where cows treated with ERE in the previous fall had a higher  
fall 2019 calving rate than those treated with MOX. This may indicate that the effect on worm 
burdens had a possible effect on dam immunity. If a cow’s immunologic and resilience 
homeostatic mechanisms are not being taxed by worm infection, such as in the ERE cattle, then 
the cycling cow would have an increased ability to conceive, as disturbed immune function has 
been identified as a primary component to infertility (Fair, 2015).  
Future studies should focus on the investigation of interactions between fecal egg counts 
and immune status within cycling beef cows. The observed tendency which reflects a higher 
pregnancy rate and calving rate in ERE treated cows compared to MOX treated cows could be 
partly attributed to the fact the sample size of MOX cows in this study was smaller than the CON 
and ERE groups. Though there was an observed tendency for higher fall 2019 pregnancy rates in 
relation to cow treatment, little effects were observed in relation to proportion of pregnancy 
percentage by natural and artificial insemination of cows within treatment groups. Although 
there was an observed tendency for CON cows to have fewer A.I. confirmed pregnancies 
compared to MOX and ERE groups, upon further investigation into Figure 4, one can see that the 




ERE treated groups. Lastly, for cow reproductive performance, it is important to note the 
observed trend in calving date differences among cow treatment groups. In this study, there was 
an observed trend for CON cows to calve later in the subsequent 2019 calving season compared 
to those cows that were treated previously in 2018. Note, that earlier it was stated that in this 
study, there was an observation that CON cows also tended to have a lower BCS throughout the 
project duration. This may indicate that in this study there was an observed interaction between a 
lower BCS and a later subsequent calving date. This interaction is supported by previous 
literature (Herd and Sprott,1986) that states a lower BCS post calving prompts an extended 
period before a return to estrus, thus extending both the time until a future confirmed pregnancy 
and subsequently, the calving interval.  
Calf Performance Discussion 
In this study, there was no observed difference in FEN treated or CON calves in regards 
to body weight or average daily gain over the 55 days prior to weaning. These production 
parameters were also unaffected by previous dam treatment, which could be due to the fact that 
both dams and calves, in all treatment groups, had low level parasitic infections throughout the 
study period.  
In this study, there was also no observed effect on calf birth weight, which is again most 
likely attributed to the short interval between dam treatment and calf birth. There was however, 
observed differences on calf 205-day adjusted calf weaning weight and calf FEC in relation to 
dam treatments. In the results, it is observed that the calves born from anthelmintic treated cows 
had an additional 9.95 kg of body weight in their 205-day adjusted weaning weight compared to 
calves born from CON cows who did not receive any treatment. In addition to this, it was also 




study compared to calves that were born from CON cows. The implications here are that pre-
calving anthelminthic treatment of the dam could be beneficial in order to increase weaning 
weight and curtail calf worm burden in a beef cow calf operation. Both a higher weaning weight 
and lower worm burden could lend a hand in a greater immune competence of the calves, which 
may enhance their ability to gain weight and fight parasitic infections after the weaning period. 
Future studies should investigate if prior dam anthelmintic treatment will go on to affect calf 
performance measurements and FEC from the time of birth until the end of the stocker 
/beginning of the feedlot phase.  
CONCLUSION 
In conclusion, though there were not many observed treatment associated differences in 
this study, there is still need for further investigations of anthelmintic intervention and resultant 
performance of cow calf pairs who are naturally infected with internal parasites. These studies 
should include animals with higher, and more common levels of parasitic infection to accomplish 
a moderate infection (200 to 800 eggs per gram), in order to get an accurate observation of 
parasitic effect on performance prior to treatment. With infection levels similar to these very 
light infections observed in this study, it would not be in the producer’s best interest to treat cows 
with an anthelminthic. Treatment of animals with anthelminthic products at low infection levels 
significantly increases the likelihood of producing genetically resistant worms, while at the same 
time not reaping the benefits of curbing economically significant levels of parasitism. However, 
a producer should still strive to maintain parasitism below economic thresholds, a scenario that 
requires regular treatments.   
In the same way that no two cow calf operations are the same, parasitic infections in 




to combat internal parasitism within their herd based on their resources, time, and acceptable 
associated costs. With the ever increasing prevalence of anthelmintic resistance in our livestock 
(Kaplan and Vidyashankar, 2012), it is becoming increasingly more important to strategically 
combat internal parasitism by using multifaceted integrated parasite management systems 
(Maqbool et al., 2017). Now more than ever the agricultural community can prosper from current 
and future studies like this one, which investigates the efficacy of the anthelmintic products 
available to ensure animal performance measures are continuing to be met in order to feed our 
increasing population both in the U.S. and around the world.  
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Table 1. Bodyweight (BW) measurements of fall calving multiparous beef cows treated prior to calving with either Moxidectin or 
Extended Release Eprinomectin 
                          _      Treatmentsa                         SEMb               P-Valuec           CON VS TREATEDd               MOX VS EREd 
Item       MOX     ERE       CON  
BW, kg 
d0  575.4      573.7        572.1                      8.7             0.97                              0.85                                            0.90 
d80  530.4   539.7        521.3                    10.8                    0.57                               0.99                       0.29 
d162  559.1   553.7        552.7          8.2                    0.89                0.64                               0.94 
d217  520.7   515.6      515.4                      7.8                    0.90                             0.66                         0.98  
Overall   546.4       545.7        540.4                      4.5                     0.97                               0.38                         0.92 
 
a CON= control; MOX= moxidectin; ERE= extended release eprinomectin 
b SEM= pooled SEM 
c Cow BW, total gain, BCS, and FEC were analyzed using MIXED procedures of SAS 
d CON VS TREATED and MOX VS ERE values were analyzed by orthogonal contrasts 






Figure 1. Mean (±SEM) weights (kg) of cow treatment groups: control, injectable moxidectin 
(0.2mg/kg of BW); injectable extended release eprinomectin (1mg/kg of BW) recorded on d0, 
80, 162, and 217 of the study. N=38 CON; 30 MOX; 38 ERE cows per treatment group. 
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Table 2.  Body Condition Score (BCS) measurements of fall calving multiparous beef cows treated prior to calving with either 
Moxidectin or Extended Release Eprinomectin 
                   ___Treatmentsa                        SEMb              P-Valuec                      CON VS TREATED                            MOX VS ERE 
Item      MOX   ERE     CON  
BCSd 
d0             6.9  6.8            6.6           0.1                                              0.23                                      0.21                                     0.23 
d80   5.4         5.4            5.3                0.1                                       0.82                          0.74          0.59 
d162   5.1         4.9            4.9                                   0.1                                              0.22                          0.08          0.83 
d217        4.4         4.4            4.1                               0.2                                              0.48                               0.67                        0.25 
Overall   5.4x       5.4x           5.2y                               0.1                                       0.08                          0.03           0.48 
a CON= control; MOX= moxidectin; ERE= extended release eprinomectin  
b SEM= pooled SEM 
c COW BW, total gain, BCS, and FEC were analyzed using MIXED procedures of SAS 
d 1 to 9 scale; 1= emaciated; 9= obese; (14Wagner et al., 1998) 










Figure 2. Mean (±SEM) BCS of cow treatment groups: control; injectable moxidectin (0.2mg/kg 
of BW); injectable extended release eprinomectin (1mg/kg of BW) recorded on d0, 80, 162, and 
217 of the study. N=38 CON; 30 MOX; 38 ERE cows per treatment group.  
†BCS measured using 1 to 9 scale; 1= emaciated; 9= obese; (Wagner et al., 1998) 





































































Table 3. Fecal egg count (geometric means; GM) treatment × day interaction of fall calving multiparous beef cows treated prior to 
calving with either Moxidectin or Extended Release Eprinomectin 
                                           Treatmentsa                              SEMb                                     P-Value                                CON VS TREATED                 MOX VS ERE 
Item             MOX      ERE    CON 
Overall FEC, GMc           2.1d       1.3e           2.3df                       0.1                            0.0031                                         0.03                                            0.007 
d0 (calving)         3.1g       2.0g          2.2g                        0.2               0.35          0.64                                            0.16             
d80          1.9hi      1.0ih          5.1j                 0.2             <0.0001                                      <0.0001                                       0.16                                                      
d162          2.0k      1.3k           1.6k                 0.2                       0.40                              0.88                                      0.18 
d217 (weaning)         1.5l       0.9l            1.3l           0.2                                         0.45                    0.89                               0.22                
 
aCON= control; MOX= moxidectin; ERE= extended release eprinomectin 
bSEM= pooled SEM 
cFEC= fecal egg counts 







Table 4. Fall 2018 average calving date × dam treatment interaction of  multiparous beef cows treated prior to calving in fall 2018 
with either Moxidectin or Extended Release Eprinomectin 
                                     Treatmentsa                                        P-Value            CON VS TREATED              MOX VS ERE 
Item                      MOX            ERE            CON         
 
Calving Date        9/25/18         9/26/18       9/26/18                             0.96                                                    0.96                                                   0.79  
   
aCON= control; MOX= moxidectin; ERE= extended release eprinomectin 






Table 5. Subsequent (fall 2019) reproductive performance measurements of multiparous beef cows treated prior to calving in fall 2018 
with either Moxidectin or Extended Release Eprinomectin 
                                           Treatmentsa                         SEMb                           P-Valuec           CON VS TREATED                    MOX VS ERE 
Item                MOX     ERE     CON  
Pregnancy 
 Rate d, %                     77              92         82                      ---                                       0.18                                     0.55                                       0.07 
 
Calving                      67xz            92y        82zy                      ---                                       0.03                             0.87                                       0.007 
Rate c, %       
  
a CON= control; MOX= moxidectin; ERE= extended release eprinomectin 
b SEM= pooled SEM 
c Pregnancy rate and calving rate was analyzed using GENMOD 
d Percent cows confirmed pregnant within each treatment 
e Percent cows that calved within each treatment group  








Figure 3.Mean (±SEM) calving rates of fall calving cow treatment groups control, injectable 
moxidectin (0.2mg/kg of BW) ; injectable extended release eprinomectin (1mg/kg of BW). N=38 
CON; 30 MOX; 38 ERE cows per treatment group. 























Eprinomectin or Moxidectin Dam Treatment Effect 










Figure 4. Mean (±SEM) pregnancy rates by natural pregnancy and by artificial insemination of 
fall calving cow treatment groups control, injectable moxidectin (0.2mg/kg of BW) ; injectable 
extended release eprinomectin (1mg/kg of BW). N=38 CON; 30 MOX; 38 ERE cows per 
treatment group.  




































Eprinomectin or Moxidectin Dam Treatment  Effect on Subsequent Fall 
2019 Pregnancy Rate by Natural Breeding and A.I.
% NAT Preg/ Overall
Preg Rate













Table 6. Subsequent (fall 2019) average calving date × dam treatment interaction of multiparous beef cows treated prior to calving in 
fall 2018 with either Moxidectin or Extended Release Eprinomectin 
                                     Treatmentsa                                        P-Value            CON VS TREATED              MOX VS ERE 
Item                      MOX            ERE            CON         
 
Calving Date        9/16/19         9/20/19       9/23/19                            0.23                                                    0.11                                                   0.35  
   
aCON= control; MOX= moxidectin; ERE= extended release eprinomectin 








Figure 5.Mean (±SEM) calf birthweight (kg) analyzed by dam treatment. Dam treatments were 
CON, n=38; injectable moxidectin (0.2mg/kg of BW) MOX, n= 30; injectable extended release 
eprinomectin (1mg/kg of BW) ERE, n= 38. 





























Figure 6. Mean (±SEM) weights (kg) of calf treatment groups: negative control, CON 
(n = 53) and oral drench fenbendazole (5mg/kg of BW), FEN (n = 53) recorded on d162 and 
d217 of the study.  






Figure 7. Mean (± SEM) average daily gain (kg/day) of CON (n = 53) and oral drench 
fenbendazole (5mg/kg of BW) - FEN (n = 53) calves from d162 - d217 of the study.  


























Fenbendazole Treatment Effect on Calf ADG 55 Days 






















































Fenbendazole Treatment Effect on Calf  BW 55 Days 









Figure 8. Mean (±SEM) 205 day adjusted weaning weights of calves analyzed by orthogonal 
contrast of control vs. treated in regards to dam treatment. Dam treatments were CON, n=38; 
injectable moxidectin (0.2mg/kg of BW) MOX, n= 30; injectable extended release eprinomectin 
(1mg/kg of BW) ERE, n= 38. 






Figure 9. Mean (±SEM) 205 day adjusted weaning weights of calves analyzed by dam treatment. 
Dam treatments were CON, n=38; injectable moxidectin (0.2mg/kg of BW) MOX, n= 30; 
injectable extended release eprinomectin (1mg/kg of BW) ERE, n= 38. 











































Eprinomectin or Moxidectin Dam Treatment 





















Figure 10. Mean (± SEM) FEC (eggs per gram) from d 162 - d 217 for control (CON), and oral 
fenbendazole drench (5mg/kg) (FEN) treated calves.  






Figure 11. Mean (±SEM) FEC (eggs per gram) of calves on d 162 analyzed by dam treatment 
interaction. Dam treatments were CON, n=38; injectable moxidectin (0.2mg/kg of BW) MOX, 
n= 30; injectable extended release eprinomectin (1mg/kg of BW) ERE, n= 38.  




























Eprinomectin or Moxidectin Dam Treatment Effect 
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Fenbendazole Treatment effect on Calf FEC 55 Days 
Prior to Weaning and at Weaning
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